Southern Cross University

Bachelor of Clinical Sciences (Osteopathic Studies)

Southern Cross University

Type of institution: University/Higher Education Institution
Level: Undergraduate
CRICOS: 01241G

The Bachelor of Clinical Sciences (Osteopathic Studies) is a pathway towards a career in osteopathy. Providing a comprehensive grounding in anatomy and physiology, you’ll develop deep knowledge of the connections between the structure and function of your bones, joints, muscles and nerves. With experience drawn from a clinical setting, and complemented by teaching around biomedical science and health, you’ll gather essential knowledge into how our bodies function and why, and what to do when those functions falter. The course includes the study of advanced levels of anatomy and physiology, particularly the structure and function of the muscular and nervous systems.

Structure

Must complete the equivalent of 24 units (288 credit points), comprising: 24 core units (288 credit points).

Subjects

  • Osteopathic studies
  • Anatomy
  • Physiology
  • Diagnosis
  • Neuroscience

Standard entry requirements

Australian Year 12

Recognition

Osteopathy Board of Australia

Study pathways

This course offers an intermediate award (early exit point) at Associate Degree level. To become a registered osteopath, successful completion of the Bachelor of Clinical Sciences (Osteopathic Studies) and the Master of Osteopathic Medicine is required. Graduates of the Bachelor of Clinical Sciences (Osteopathic Studies) receive four units of advanced standing into the Southern Cross University Master of Osteopathic Studies.

Study information

CampusFeesMid year intakeAttendance
Gold Coast International: $88,080 Yes
  • Full-time : 3 years
  • Part-time : 6 years
Lismore International: $88,080 Yes
  • Full-time : 3 years
  • Part-time : 6 years

Related courses

Browse more courses
Is the information on this page correct? Request update
Enquire about this course

Are you currently in Australia?

You must agree before submitting.

Subscribe to our newsletter

Join the conversation